show that the anti-obesity 5-HT2CR agonist lorcaserin targets both the POMC circuitry of the hypothalamus and the brainstem nucleus of the solitary tract (5-HT2CRNTS) to mediate appetite suppression. The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.